 Bronchodilator Agents
"Bronchodilator Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that cause an increase in the expansion of a bronchus or bronchial tubes.
| Descriptor ID |
D001993
|
| MeSH Number(s) |
D27.505.696.663.050.110 D27.505.954.796.050.100
|
| Concept/Terms |
Bronchodilator Agents- Bronchodilator Agents
- Agents, Bronchodilator
- Bronchial-Dilating Agents
- Agents, Bronchial-Dilating
- Bronchial Dilating Agents
- Bronchodilators
Broncholytic Effect- Broncholytic Effect
- Effect, Broncholytic
- Broncholytic Effects
- Effects, Broncholytic
Bronchodilator Effect- Bronchodilator Effect
- Effect, Bronchodilator
- Bronchodilator Effects
- Effects, Bronchodilator
|
Below are MeSH descriptors whose meaning is more general than "Bronchodilator Agents".
Below are MeSH descriptors whose meaning is more specific than "Bronchodilator Agents".
This graph shows the total number of publications written about "Bronchodilator Agents" by people in this website by year, and whether "Bronchodilator Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 | | 1995 | 0 | 1 | 1 | | 1996 | 0 | 1 | 1 | | 1998 | 3 | 1 | 4 | | 1999 | 4 | 0 | 4 | | 2000 | 3 | 3 | 6 | | 2001 | 0 | 2 | 2 | | 2002 | 3 | 1 | 4 | | 2003 | 1 | 2 | 3 | | 2004 | 4 | 1 | 5 | | 2005 | 5 | 4 | 9 | | 2006 | 5 | 2 | 7 | | 2007 | 2 | 0 | 2 | | 2008 | 7 | 4 | 11 | | 2009 | 5 | 0 | 5 | | 2010 | 3 | 1 | 4 | | 2011 | 8 | 4 | 12 | | 2012 | 4 | 4 | 8 | | 2013 | 5 | 2 | 7 | | 2014 | 2 | 1 | 3 | | 2015 | 5 | 2 | 7 | | 2016 | 4 | 5 | 9 | | 2017 | 5 | 3 | 8 | | 2018 | 4 | 3 | 7 | | 2019 | 9 | 5 | 14 | | 2020 | 3 | 0 | 3 | | 2021 | 2 | 7 | 9 | | 2022 | 2 | 2 | 4 | | 2023 | 0 | 6 | 6 | | 2024 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Bronchodilator Agents" by people in Profiles.
-
Huang J, Moss A, Hoyt BM, Watson JD, Brittan MS. Factors Associated with Inhaled Bronchodilator and Oral Corticosteroid Use in Young Children with First Lower Respiratory Tract Infection. J Pediatr. 2024 Apr; 267:113912.
-
Mosnaim GS, Hoyte FCL, Safioti G, Brown R, Hill TD, Li T, Sagalovich K, DePietro M, Wechsler ME. Effectiveness of a Maintenance and Reliever Digihaler System in Asthma: 24-Week Randomized Study (CONNECT2). J Allergy Clin Immunol Pract. 2024 02; 12(2):385-395.e4.
-
Ho JK, Shaker M, Greenhawt M, Sadatsafavi M, Abrams EM, Oppenheimer J, Mosnaim GS, Lee TY, Johnson KM. Cost-effectiveness of budesonide-formoterol vs inhaled epinephrine in US adults with mild asthma. Ann Allergy Asthma Immunol. 2024 02; 132(2):229-239.e3.
-
Perez-Garcia J, Pino-Yanes M, Plender EG, Everman JL, Eng C, Jackson ND, Moore CM, Beckman KB, Medina V, Sharma S, Winnica DE, Holguin F, Rodr?guez-Santana J, Villar J, Ziv E, Seibold MA, Burchard EG. Epigenomic response to albuterol treatment in asthma-relevant airway epithelial cells. Clin Epigenetics. 2023 10 03; 15(1):156.
-
Thomas D, McDonald VM, Stevens S, Harvey ES, Baraket M, Bardin P, Bowden JJ, Bowler S, Chien J, Chung LP, Gillman A, Hew M, Hodge S, James A, Jenkins C, Katelaris CH, Katsoulotos GP, Langton D, Lee J, Marks G, Peters M, Radhakrishna N, Reynolds PN, Rimmer J, Sivakumaran P, Upham JW, Wark P, Yang IA, Gibson PG. Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients. Allergy. 2024 02; 79(2):384-392.
-
De Keyser H, Vuong V, Kaye L, Anderson WC, Szefler S, Stempel DA. Is Once Versus Twice Daily Dosing Better for Adherence in Asthma and Chronic Obstructive Pulmonary Disease? J Allergy Clin Immunol Pract. 2023 07; 11(7):2087-2093.e3.
-
Ozkaynak M, Amura CR, Sills MR, Topoz I. Effects of a QI intervention on pediatric asthma treatment using patient outcomes and workflow in an emergency department. J Asthma. 2023 08; 60(8):1573-1583.
-
Mintz M, Barjaktarevic I, Mahler DA, Make B, Skolnik N, Yawn B, Zeyzus-Johns B, Hanania NA. Reducing the Risk of Mortality in Chronic Obstructive Pulmonary Disease With Pharmacotherapy: A Narrative Review. Mayo Clin Proc. 2023 02; 98(2):301-315.
-
Fortis S, Quibrera PM, Comellas AP, Bhatt SP, Tashkin DP, Hoffman EA, Criner GJ, Han MK, Barr RG, Arjomandi M, Dransfield MB, Peters SP, Dolezal BA, Kim V, Putcha N, Rennard SI, Paine R, Kanner RE, Curtis JL, Bowler RP, Martinez FJ, Hansel NN, Krishnan JA, Woodruff PG, Barjaktarevic IZ, Couper D, Anderson WH, Cooper CB. Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD. Chest. 2023 03; 163(3):502-514.
-
Wise RA, Holbrook JT, Brown RH, Criner GJ, Dransfield MT, He J, Henderson RJ, Kaminsky DA, Kaner RJ, Lazarus SC, Make BJ, McCormack MC, Neptune ER, Que LG. Clinical Trial of Losartan for Pulmonary Emphysema: Pulmonary Trials Cooperative Losartan Effects on Emphysema Progression Clinical Trial. Am J Respir Crit Care Med. 2022 10 01; 206(7):838-845.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|